




















Development and application of a delayed-release
anthelmintic intra-ruminal bolus system for experimental
manipulation of nematode worm burdens
ANJA M. CARLSSON1,2,3*, KENNETH WILSON1 and R. JUSTIN IRVINE2
1Lancaster Environment Centre, Lancaster University, Lancaster LA1 4YQ, UK
2The James Hutton Institute, Craigiebuckler, Aberdeen AB15 8QH, UK
3Department of Arctic Biology, University Centre in Svalbard, PO Box 156, NO-9171 Longyearbyen, Norway
(Received 7 December 2011; revised 9 February 2012; accepted 12 February 2012; first published online 15 March 2012)
SUMMARY
In order to quantify the impact of parasites on host population dynamics, experimental manipulations that perturb the
parasite-host relationship are needed but, logistically, this is difficult for wild hosts. Here, we describe the use of a delayed-
release anthelmintic delivery system that can be administered when the hosts can be captured and its activity delayed until a
more appropriate period in the host-parasite cycle. Our model system is Svalbard reindeer infected with a nematode
parasite,Marshallagia marshalli, which appears to accumulate during the Arctic winter. To determine the extent to which
this occurs and the effect on host fitness, reindeer need to be treated with anthelmintics in late autumn but they can only be
caught and handled in April. To solve this problem, we devised an intra-ruminal capsule that releases the anthelmintic from
up to 6 months after being administered. The capsule was trialed in cannulated sheep and red deer to determine optimum
capsule orifice size and release rates. Capsules were estimated to release placebo for 100–153 days followed by abamectin for
22–34 days. To test the efficacy of treatment in reindeer, capsules were administered in April and retrieved in October. All
capsules had fully released the anthelmintic and treated reindeer had significantly lower worm burdens than controls. Thus,
success of this system allows repeated treatment over several years to test the effect of winter parasitism on host fitness.
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INTRODUCTION
Theoretical studies have shown that parasites have
the potential to regulate host abundance through
effects on reproduction and survival of the host
(Anderson and May, 1978; May and Anderson,
1978). In spite of the increasing recognition of the
importance of parasites in population ecology and
wildlife conservation, knowledge of host-parasite
interactions in the wild remains limited (Smith
et al. 2009). In domesticated livestock it is well rec-
ognized that gastrointestinal nematodes cause sig-
nificant disease through negative effects on growth
and survival of the host, resulting in major economic
losses (Perry and Randolph, 1999). Consequently,
the ecology of parasites in agricultural systems has
been studied in detail in order to understand howbest
to control and limit disease (Alison, 2003; O’Connor
et al. 2006). Traditionally, the study of parasites in
wild animals has relied on making assumptions based
on domesticated animals. However, the epidemiol-
ogy of host-parasite dynamics in thewild is often very
different. At best, cross-sectional studies of carcasses
and fecal egg counts can be carried out (Morgan et al.
2005; Newey et al. 2005; Irvine et al. 2006); however,
the consequences of parasitism are difficult to deter-
mine through these types of studies (Gulland, 1995;
Stien et al. 2002; Wilson et al. 2002). To investigate
the effects of parasitism on the host, experiments that
perturb the host-parasite relationship are essential
(Stien et al. 2002). One of the major constraints
in conducting such experiments is the logistical
difficulties associated with accessing, treating and
handling wild animals.
Experimental perturbations of the parasite com-
munities in wild animals generally rely on the use of
anthelmintics to reduce parasite burdens (Murray
et al. 1996; Irvine, 2000; Craig et al. 2009). However,
the ability to reduce worm burdens experimentally is
limited to the time when anthelmintics can be
administered and the duration of the effective treat-
ment period. Usually, a single oral dosing or injection
is used to deliver the anthelmintic in thewild (Murray
et al. 1997; Hudson et al. 1998; Irvine, 2000; Newey
et al. 2005; Pedersen and Greives, 2008) and the
period of efficacy is generally a maximum of 3–5
weeks. However, slow-release intra-ruminal devices
have been developed for livestock which deliver a
therapeutic dose over a period of up to 100 days
(Cardinal, 1997;VandammeandEllis, 2004) reducing
both labour and material costs in the control of
nematode parasites. These devices have advantages
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for wildlife research, allowing a single treatment to
provide a lengthy parasite-free period in animals that
are difficult to catch or can be caught only at specific
times of the year.
The application of slow-release capsules has been
successfully utilized on Soay sheep (Gulland et al.
1993) and Svalbard reindeer (Rangifer tarandus
platyrhynchus) (Stien et al. 2002). In the latter case,
these capsules were administered to reindeer in April,
which reduced worm burdens for approximately
3 months and confirmed that Ostertagia gruehneri
transmission occurs in spring (Albon et al. 2002).
Furthermore, treatment also demonstrated that there
was a parasite-mediated reduction in host fecundity
that was sufficient to regulate the population
dynamics of Svalbard reindeer (Albon et al. 2002).
However, cross-sectional studies have also indicated
that the other major nematode species of Svalbard
reindeer (Marshallagia marshalli) is almost absent
during the summer but increases during winter,
suggesting over-winter transmission, but the conse-
quence of this infection on reindeer performance
has not yet been quantified (Irvine et al. 2000). To
determine the transmission dynamics ofM.marshalli,
and the impact of the parasite on the fecundity and
survival of the host, an experiment is needed in which
reindeer are treated at the start of thewinter.However,
logistical and environmental constraints make it
impossible to catch and treat animals at this time of
year.
In this study, we describe the adaptation and
application of a delayed-release anthelminitic deliv-
ery system. Domestic sheep and farmed red deer
(Cervus elaphus) were used as model systems, and the
efficacy was tested against the abomasal nematodes of
Svalbard reindeer. The aim was to develop a device
that can be administered in April when Svalbard
reindeer can be most easily caught, but to delay
delivery of the anthelmintic until autumn several
months later. This would then allow quantification of
the effect of winter parasitism on host fitness
parameters in a later study. We predicted that
Svalbard reindeer treated with the delayed-release
bolus would have significantly lower worm burdens
in October compared to controls.
MATERIALS AND METHODS
Capsule design
Capsules used in this study were small slow-release
intra-ruminal capsules (Argenta Manufacturing
Limited, NZ) that comprise a plastic hollow cylinder
capped at both ends containing up to 11 tablets
(identical in size and mode of action to the capsules
used by Stien et al. (2002)). One end is closed and
includes a spring that pushes the tablets towards the
orifice in the opposite end. The orifice allows rumen
fluid to enter the capsule and sequentially dissolves
the tablets within the cylinder; the resulting gel is
pushed out of the capsule at a rate determined by the
size of the orifice. Retention of the capsule in the
rumen is achieved by polymeric wings attached to
the cylinder. During administration, the wings are
constrained to the cylinder with water-soluble tape,
subsequently the tape dissolves and the wings open,
preventing regurgitation of the device. Each capsule
was fitted with a unique identifying number to ensure
traceability and linking the capsule to batch number,
formulation code, orifice size, spring strength,
plunger type, capsule type and date of manufacture.
All capsules were administered orally using a capsule
applicator gun.
Rumen-cannulated sheep
The trial was carried out using 3 rumen-cannulated
sheep held at the Macaulay Land Use Research
Institute’s Glensaugh research farm, Aberdeenshire,
Scotland (56.8°N, 2.6°E), in July 2005. The duration
of release from slow-release capsules fitted with
orifices of 4·0, 3·7 and 3·5 mmdiameter and thickness
of 2 mm was determined. Each capsule contained
9 tablets of placebo (35% hydrated aluminium
silicate) followed by 2 tablets containing 3·2%
abamectin. Each sheep was fitted with 2 capsules of
each size (total of 6 capsules per sheep). The capsules
were attached to silicon tubing using cable ties and
tethered to the cannula bung. The capsules were
retrieved from the sheep rumens on days 0, 24, 50, 78
and 106 and the core length of each capsule was
measured using vernier calipers from the lower edge
of the plunger (coloured red to aid visibility) to the
inner edge of the orifice plate. Not all capsules were
recovered at all sampling dates, as some were lost
when they became detached from the silicon tubing
that tethered them to the cannula bung.
Release rates, defined as the reduction in tablet size
(mm per day since capsule administration), were
calculated from the core-length measurements using
linear mixed effect models from the lme package in
R version 2.13.0 (R Development Core Team, 2011),
with sheep identity and capsule as random effects,
and days since initiation of experiment and orifice
size as fixed effects. Model fit was assessed using
diagnostic plots of fitted values and residuals. Log-
transforming the response variable improved model
fit and linearized the data. However, estimates from
this model were unrealistic, predicting periods of
release on a log-scale (>460 days) well in excess of
those observed (e.g. we know that capsules from
reindeer culled 6 months after treatments were fully
discharged).
Red deer
From trials in sheep it was determined that the
smallest orifice size was the most appropriate design
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and the release rate of capsules was tested in red deer.
The trial was carried out using red deer at the
Glensaugh research farm (see above). Six yearling red
deer were each given 1 capsule with 11 placebo (35%
hydrated aluminum silicate) tablets and orifice
diameter of 3·5 mm and thickness of 2 mm on days
0, 36, and 63 of the experiment. The animals were
kept under normal management until they were
slaughtered on day 100 of the experiment and all
capsules recovered from the rumen. At the end of the
experiment, the core-length of each capsule was
measured as described above. All capsules were
successfully retrieved and identified by the end of
the trial. Release rate, as defined above, was predicted
using linear mixed effect models using the lme
package in R version 2.13.0 (R Development Core
Team, 2011) with deer identity as a random effect and
days since capsule administration until cull as a fixed
effect.
Svalbard reindeer
Svalbard reindeer are a wild population living on the
high Arctic archipelago of Svalbard (Halvorsen and
Bye, 1999). Female Svalbard reindeer have been
marked and caught annually in the Colesdalen-
Reindalen valley system, Nordenskiöldland,
Spitsbergen (77°50–78°20N, 15°00–17°30E) since
1994, allowing treatment and recapture of known
individuals (Milner et al. 2003). Between 11–26 April
2006 and 2007, 62 adult female reindeer (36 months
or older) were randomly allocated for treatment and
fitted with an intra-ruminal controlled-release cap-
sule with an orifice diameter of 3·5 mm and thickness
of 2 mm. Each capsule contained 9 tablets of placebo
and 2 tablets abamectin, in order to delay treatment
until autumn. In 2006 the concentration of abamectin
in tablets was 3·2%. In their original design, the
estimated dose rate with abamectin of this concen-
tration was 23 μg/kg/day; however, these figures were
based on sheep weighing 80 kg, using capsules with
orifice diameter of 4·5 mm. The orifice diameter of
the reindeer capsules was smaller, and it is therefore
likely that the abamectin dose rate was lower. The
following year the abamectin dose was doubled (to
6%) to compensate for the smaller orifice size in the
delayed release capsules, with estimated delivery rate
of 45 μg/kg/day. Administration of capsules was
performed as outlined above. To assess the efficacy
of the treatment, 16 control and 4 treated animals
were culled in late October 2006 and 2007 and the
abomasums recovered 186–194 days after adminis-
tration. Stien et al. (2002) have previously reported
on an experiment where animals were treated with
immediate-acting anthelmintic drugs in April, using
ivermectin capsules (Ivomec Maximizer, Merial
Animal Health Ltd, Harlow Essex, UK) and/or
injectable moxidectin, to reduce worm burdens in
Svalbard reindeer during the summer.Todemonstrate
the difference in efficacy between the immediate, and
delayed anthelmintic drug treatment in removing
nematode burdens in October, a subset of these data
was analysed. Abundance data of M. marshalli and
O. gruheneri adult worms from 7 Svalbard reindeer
treated with immediate-acting anthelmintics and
10 non-treated Svalbard reindeer culled October
1999 were used. For more details of these exper-
iments see the report by Stein et al. (2002).
Abomasums were removed from culled reindeer
and adult nematodes were extracted and counted as
described by Halvorsen et al. (1999) and Irvine et al.
(2000). A subset of adult male nematodes was
identified to species using morphology (Drozdz,
1965), with minor and major morphs grouped
according to recent molecular findings (Dallas et al.
2000, 2001). Adult nematode abundance for each
species was estimated using the proportion of
identified worms and scaling up to the population
level based on the worm counts. The effect of the 3
different treatments (control, immediate-acting an-
thelmintic and delayed-release anthelmintic capsule)
on adult nematode worm burden was analysed using
generalized linear models with a log link function,
assuming the nematode counts came from a negative
binomial distribution (Wilson et al. 1996). For
animals treated with delayed-release capsule, a
separate analysis was run to check for differences in
treatment efficacy between the 2 treatment years
(2006 and 2007). Data were analysed using the glm.
nb function from the MASS package in R version
2.13.0 (R Development Core Team, 2011).
Animal ethics
All procedures on red deer and sheep were carried out
by R. J. Irvine, who has a personal license (PIL 60/
11369) issued by the UK Government Home Office
under the Scientific Procedures on Living Animals
Regulations (Animals (Scientific Procedures) Act
1986). All capture and live-animal procedures on
Svalbard were performed under license from the
Norwegian National Animal Research Authority
with a veterinary surgeon in attendance.
RESULTS
Rumen-cannulated sheep
As expected, the core length in all capsules decreased
significantly over time (F1,56=1305, P<0·001), and
the rate of decrease varied significantly with orifice
size (F2,56=7·56,P=0·0012) (Fig. 1). The core length
of capsules with orifice diameter of 4·0 mm declined
the fastest (t2,56=3·5, P<0·001), with an estimated
mean release rate of 0·46 (±0·03) mm per day. There
was no significant difference in core length decline
rate in capsules with an orifice diameter of 3·5 and
3·7 mm (t1,56=0·29, P=0·76), which had estimated
rates of release of 0·35 (±0·02) and 0·36 (±0·03) mm
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per day, respectively. Based on the tablet release rate
of the capsule with the smallest orifice size, all tablets
were predicted to be released in 183 (±9) days, with 1
tablet being dissolved approximately every 17th day
after administration (Fig. 1). There was no evidence
of clogging or blockage of the orifice in any of the
capsules.
Red deer
The core length in all capsules decreased significantly
over time (F1,17=1825, P<0·001); the estimated
release rate of capsules with orifice diameter of
3·5 mm was 0·51 (±0·01) mm per day. In deer, the
estimated time until all tablets were released was
therefore 125 (±2) days (Fig. 2), with 1 tablet being
dissolved every 11th day. None of the administered
capsules were blocked or clogged upon retrieval.
Svalbard reindeer
Since the sheep and deer trials suggested the delayed-
release capsules lasted for between 4 and 6 months,
reindeer were culled 186–194 days after capsule
administration. All capsules recovered from treated
reindeer had successfully released all tablets. A photo
of a capsule before administration and after recovery
from the rumen following successful release of tablets
can be seen in Fig. 3. Counts of O. gruehneri adult
worms of Svalbard reindeer culled in October
showed that treated animals overall had lower worm
burdens than controls (χ22,35=45·48, P<0·001), but
that those treated with delayed-release anthelmintic
capsule also had significantly lower O. gruheneri
burdens than those animals treated with immediate-
acting anthelmintics (z2,35=−4·235, P<0·001;
Fig. 4a). For O. gruehneri there was also a
Fig. 2. Estimated rate of decline of the core length of
intra-ruminal capsules with an orifice diameter of 3·5 mm
in red deer. Symbols indicate means±standard errors as
predicted from the minimal model, standardized for 1
animal.
Fig. 3. Photo of the delayed-release intra-ruminal bolus
before administration (bottom) and after recovery from
the rumen following successful release of all anthelmintic
tablets (top).
Fig. 1. Estimated rate of decline of the core length of
intra-ruminal capsules with an orifice diameter of 3·5
(solid lines), 3·7 (dashed lines) and 4·0 (dotted lines) mm
in rumen-cannulated sheep. Symbols indicate
means±standard errors from the minimal model,
standardized for 1 animal.
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between-year difference (χ21,18=51·2, P<0·001),
where the effect of the delayed treatment was stronger
and worm burdens significantly lower in animals
treated in 2007, when the abamectin dose rate was
higher, compared with those treated in 2006. For
M. marshalli only the delayed-release anthelmintic
capsule successfully reduced worm burdens in
October (z2,35=−4·585, P<0·001), there being no
significant difference in M. marshalli burdens be-
tween the non-treated control animals and animals
treated with immediate-acting anthelmintic capsule
(z2,35= −1·349, P=0·177; Fig. 4b). There was no
difference in treatment effect of the delayed-release
anthelmintic capsule between years for M. marshalli
burdens (χ21,16=1·768, P=0·18).
DISCUSSION
This study demonstrates that, through the modifi-
cation of the intra-ruminal capsule design, and the
use of a combination of placebo and therapeutic
tablets, we were able to delay delivery of anthelmin-
tics to individuals in a wild animal population. This
novel method allows us to experimentally manipulate
parasite burdens at a time of year when it is
impossible to treat animals by any other method.
Thus, we have developed amechanism that will allow
us to test the magnitude and effect of over-winter
transmission of parasites during the harsh Arctic
winter when hosts are already under severe nutri-
tional stress.
To overcome logistical and management con-
straints associated with working with free-ranging
wild animals, we used sheep and deer models to
determine optimal capsule design. For intra-ruminal
devices where drug delivery is based on diffusion, the
rate of release is governed by the size of the orifice: if
the orifice is too small it can lead to build-up of tablet
residue, which will block the orifice and prevent the
remaining anthelmintic from being released.
Therefore, release rates from capsules fitted with
different size orifices were first established in sheep
with the aim of determining the smallest size orifice
with release rates that would allow administration of
the bolus up to 6 months prior to the drug being
released. Release rates of the capsule with the 3·5 mm
orifice size were then trialed in red deer. Release rates
were faster in deer, with an estimated 125 days until
all tablets were dissolved compared to 183 days in
sheep. This variation could, in part, be due to the
difference in methodology between the two trials.
Whilst the deer had an intact rumen, the sheep were
fitted with an intra-ruminal cannula in order to allow
repeated measurements of the same capsule.
Tethering the capsule to the bung changes normal
capsule movement in the rumen, and each time the
cannula is removed the rumen environment is
disturbed, which could have an effect on the release
rate of the tablets (Vandamme and Ellis, 2004). But
the difference in release rates could also be due to
biological differences in the rumen environment and
microflora between cervids and bovids affecting the
function of the capsule. Further, the capsules fitted in
the sheep contained 2 tablets of abamectin, whilst
those administered to deer contained only placebo
tablets. The difference in chemical composition of
these tablets may also affect the rate at which they are
dissolved (Cardinal, 1997; Vandamme and Ellis,
2004).
Since Svalbard reindeer are wild, free-ranging
animals, detailed studies of anthelmintic release
rates could not be conducted in the field because it
is not possible to cull treated individuals sequentially
over the release period. However, by culling animals
in October, approximately 6 months after adminis-
tration of the delayed-release anthelmintic capsule,
we were able to demonstrate that all tablets had
successfully dissolved, and that animals treated with
the delayed anthelmintic bolus had significantly
lower burdens of adult nematodes of both major
species compared to controls. Animals treated with
the delayed bolus still harboured abomasal nema-
todes but at much lower levels compared to controls
and those treated with immediate-acting anthelmin-
tics. The presence of low numbers of adult nematodes
in the treated animals could be because the release
rate was similar to that found in red deer (125 days),
in which case the anthelmintic would have been
Fig. 4. Estimated mean (±standard error) adult worm burdens/animal across all sampling years of (a) Ostertagia
gruehneri and (b)Marshallagia marshalli for Svalbard reindeer culled in October as predicted by best fit model.
Non-treated, control (dark grey bars), treated with immediate-acting anthelmintics (light grey bars after Stien et al.
2002), and treated with delayed-release anthelmintic capsule (open bars).
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delivered mid-August, allowing time for reindeer to
become re-infected by ingesting infective larvae from
the pasture. Although there is increasing evidence of
resistance to a range of anti-parasitic agents in
nematodes of domestic livestock, it is unlikely that
nematodes of Svalbard reindeer have significant
anthelmintic resistance. The anthelmintic used in
this trial is of the macrocyclic lactone, avermectin
class, which has good potency and broad spectrum
activity against nematodes and acarines (Shoop et al.
1995; McKellar and Jackson, 2004). Anthelmintics
of the avermectin class have been shown to be
effective and safe for treatment against nematodes
for a range of adult domesticated wild ruminants
(Marley and Conder, 2002) as well as some wild free-
ranging populations (Irvine, 2000; Craig et al. 2009).
Alternatively, the presence of low levels of adult
nematodes in the treated animals could reflect that the
dose rate of abamectin was suboptimal in capsules
with orifice diameter of 3·5 mm, but this issue could
be addressed by increasing the concentration of
abamectin to improve the therapeutic dose. In fact,
burdens ofO. gruehneri in treated animals were lower
in 2007 (285 vs 651) when the dose rate of abamectin
was increased. Nonetheless, the abundance of adult
nematodes of both major species was significantly
reduced in both treatment years. Although the
efficacy of anthelmintics in removing nematode
burdens of Svalbard reindeer in the summer has
previously been demonstrated (Stien et al. 2002),
only the delayed-release anthelmintic capsule suc-
cessfully reducedM. marshalli burdens in the winter
(Fig. 4b). Consequently, experimental treatments
with delayed-release capsules offer potential insights
into both the over-winter transmission dynamics of
the gastrointestinal nematodes of Svalbard reindeer
and their impact on host fitness.
Intra-ruminal devices revolutionized drug delivery
in agricultural systems and, as illustrated here, can be
a useful tool for studying parasite-host interactions of
wild ruminants. By modifying a readily available
commercial system, the logistical constraints associ-
ated with studying a free-ranging ruminant in the
Arctic have been overcome. There are a range of
intra-ruminal devices of different designs and modes
of action in use for the delivery of growth promoters,
nutrients and anti-parasitic drugs, all of which could
potentially be utilized in studies of wild ruminant
population ecology (Vandamme and Ellis, 2004).
Controlled release devices have for example been
used to estimate forage intake in mule deer (Kuzyk
and Hudson, 2006) and to establish the effect of trace
elements on the population dynamics of black-tailed
deer (Flueck, 1994). Although intra-ruminal devices
are now routinely used in livestock it is vital to
ascertain that the device, delivery time and dose rate
chosen is safe for the species in question, as
inappropriate designs could have adverse effects
when administered.
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